HD-OPM Archive
Topics › Inflammation & CRP

Libby vs Raal debate: residual inflammatory risk versus LDL lowering as the main driver

Louis Nervegna · Jun 20, 2025 · ♥ 4 reactions · 0 comments · original Facebook post
Inflammation & CRPLDL, ApoB & lipid panelCardiovascular disease: the big picture
↻ This is a repost. The main version (highest ranked) is Libby vs Raal debate: is inflammation or LDL the key driver of CVD risk? · Oct 19, 2024.
AI summary & key facts

A video debate in which Peter Libby argues there is residual inflammatory risk even with controlled LDL and IL-6 plays a causal role, while Derick Raal argues LDL is the primary cause and inflammation a consequence addressable by lifestyle and weight loss. Both agree on the value of addressing multiple risk factors.

#inflammationHD #colchicineHD #crpHD #il6HD #peterlibbyHD #brighamwomensHD #harvardHD #ldlHD #derickraalHD #diabetesHD #ckdHD #fhHD #weightlossHD

Research cited

Shared from Gokhan Can · original post

LDL vs. Inflammation: Debating the Drivers of Cardiovascular Risk

This video features a debate between Professor Peter Libby and Professor Derick Raal on the roles of inflammation versus LDL cholesterol lowering in cardiovascular disease risk reduction. Peter Libby argues that while LDL cholesterol is important, there is significant residual inflammatory risk even when LDL is well-controlled. He presents evidence that inflammation, particularly interleukin-6, plays a causal role in atherosclerosis and that anti-inflammatory therapies may offer additional benefit beyond lipid lowering. Libby emphasizes the need to consider multiple risk factors beyond just LDL, including inflammation, diabetes, and chronic kidney disease.

Derick Raal contends that LDL cholesterol is the primary causal factor in atherosclerosis, with inflammation being a consequence rather than a cause. He argues that more aggressive and earlier LDL lowering is needed to truly prevent cardiovascular disease, citing evidence from genetic studies and familial hypercholesterolemia. Raal acknowledges inflammation's role but believes it can be addressed primarily through lifestyle changes and weight loss rather than specific anti-inflammatory therapies. Ultimately, both speakers agree there is value in addressing both lipids and inflammation, with Libby emphasizing a multi-faceted approach and Raal prioritizing more intensive LDL reduction starting at younger ages.

← newer: Peter Libby on inflammation in atherosclerosis, clonal hematolder: Louis flags a new colchicine result as potentially very big →